PFI-14©: A Rasch Analysis Refinement of the Psoriasis Family Index

Dermatology

Volumn 231, Issue 1, 2015, Pages 15-23

  Basra, Mohammad K A ^a   Zammit, Anne Marie ^b   Kamudoni, Paul ^b   Eghlileb, Ahmed M ^c   Finlay, Andrew Y ^c   Salek, M Sam ^d,e  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^d Institute of Medicines Development   (United Kingdom)

^e UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

'Greater Patient'; Family members; PFI 14 ; Psoriasis; Psoriasis Family Index; Quality of life; Skin disease

Indexed keywords

ADULT; ARTICLE; ASSESSMENT OF HUMANS; CLINICAL RESEARCH; CONTROLLED STUDY; DIFFERENTIAL ITEM FUNCTIONING; FAMILY; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS FAMILY INDEX; PSYCHOMETRY; QUALITY OF LIFE; RASCH ANALYSIS; RATING SCALE; RELIABILITY; SECONDARY CARE CENTER; STATISTICAL ANALYSIS; FEMALE; MALE; PARENT; PSYCHOLOGY; QUESTIONNAIRE; REPRODUCIBILITY; SPOUSE; STATISTICAL MODEL;

FEMALE; HUMANS; MALE; MODELS, STATISTICAL; PARENTS; PSORIASIS; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SPOUSES; SURVEYS AND QUESTIONNAIRES;

EID: 84937525916     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000379748     Document Type: Article

References (24)

1. Basra MK, Finlay AY: The family impact of skin diseases: The Greater Patient concept. Br J Dermatol 2007; 156: 929-937.
2. Eghlileb A, Davies E, Finlay AY: Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol 2007; 156: 1245-1250.
3. Basra MKA, Sue-Ho R, Finlay AY: The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Br J Dermatol 2007; 156: 528-538.
4. Eghlileb AM, Basra MKA, Finlay AY: The Psoriasis Family Index: Preliminary results of validation of a quality of life instrument for family members of patients with psoriasis. Dermatology 2009; 219: 63-70.
5. Prieto L, Alonso J, Lamarca R: Classical test theory versus Rasch analysis for quality of life questionnaire reduction. Health Qual Life Outcomes 2003; 1: 27.
6. Tesio L: Measuring behaviours and perceptions: Rasch analysis as a tool for rehabilitation research. J Rehabil Med 2003; 35: 105-115.
7. Masters GN: A Rasch model for partial credit scoring. Psychometrika 1982; 47: 149-174.
8. Reeve B, Fayers P: Rasch models and IRT; in Fayers P, Hays R (eds): Assessing Quality of Life in Clinical Trials: Methods and Practice. Oxford, Oxford University Press, 2005.
9. Tennant A, McKenna SP, Hagell P: Application of Rasch analysis in the development and application of quality of life instruments. Value Health 2004; 7(suppl 1): S22-S26.
10. Bond TG, Fox CM: Applying the Rasch Model: Fundamental Measurement in the Human Sciences. Mahwah, Lawrence Erlbaum Associates Publishers, 2007.
11. Basra M, Camalleri L, Salek S, Finlay AY: Strengthening the Dermatology Life Quality Index's clinical meaning: minimal clinically important difference of the scores. Br J Dermatol 2010; 163(suppl 1): 41 (abstract P-47).
12. Basra M, Salek S, Fairfax M: Psoriasis Family Index (PFI-15): validation of a disease-specific quality of life tool for family members of psoriasis patients. Qual Life Res 2010; 19 (suppl 1): 102 (abstract 178/1671).
13. Shea T, Tennant A, Pallant J: Rasch model analysis of the Depression, Anxiety and Stress Scales (DASS). BMC Psychiatry 2009; 9: 21.
14. Linacre J: Understanding Rasch measurement: optimizing rating scale category effectiveness. J Appl Meas 2002; 3: 85-106.
15. Pallant JF, Tennant A: An introduction to the Rasch measurement model: An example using the Hospital Anxiety and Depression Scale (HADS). Br J Clin Psychol 2007; 46: 1-18.
16. Nijsten T, Whalley D, Gelfand J, Margolis D, McKenna S, Stern R: The psychometric properties of the Psoriasis Disability Index in United States patients. J Invest Dermatol 2005; 125: 665-672.
17. Angoff W: Use of difficulty and discrimination indices for detecting item bias; in Berk R (ed): Handbook of Methods for Detecting Test Bias. Baltimore, Johns Hopkins University Press, 1982, pp 96-116.
18. Linacre J: A User's Guide to WINSTEPS/ MINISTEPS (Rasch-Model Computer Programs). Chicago, Winsteps. com, 2009
19. Smith E: Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas 2002; 3: 205-231.
20. Tennant A, Conaghan PG: The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Care Res 2007; 57: 1358-1362.
21. Duncan PW, Bode RK, Min Lai S, Perera S; Glycine Antagonist in Neuroprotection Americans Investigators: Rasch analysis of a new stroke-specific outcome scale: The Stroke Impact Scale. Arch Phys Med Rehabil 2003; 84: 950-963.
22. Stelmack JA, Szlyk JP, Stelmack TR, Demers-Turco P, Williams RT, Moran D, Massof RW: Psychometric properties of the Veterans Affairs Low-Vision Visual Functioning Questionnaire. Invest Ophthalmol Vis Sci 2004; 45: 3919-3928.
23. Streiner DL, Norman GR: Health Measurement Scales: A Practical Guide to Their Development and Use. Oxford, Oxford University Press, 2008.
24. Hambleton RK: Good practices for identifying differential item functioning. Med Care 2006; 44(11 suppl 3): S182-S188.